Related Experiment Video
Updated: Jun 11, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
AP2 transcription factor induces apoptosis in retinoblastoma cells
Xiaodong Li1, Darryl D Glubrecht, Roseline Godbout
1Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, T6G 1Z2 Canada.
Abstract:
The underlying cause of human retinoblastoma is complete inactivation of both copies of the RB1 gene. Other chromosome abnormalities, with the most common being extra copies of chromosome arm 6p, are also observed in retinoblastoma. The RB protein has previously been shown to interact with TFAP2 transcription factors. Here, we show that TFAP2A and TFAP2B, which map to chromosome arm 6p, are expressed in the amacrine and horizontal cells of human retina. TFAP2A RNA can readily be detected in retinoblastoma cell lines and tumors; however, the great majority of retinoblastoma cell lines and tumors are completely devoid of TFAP2A protein and TFAP2B RNA/protein. Transfection of TFAP2A and TFAP2B expression constructs into retinoblastoma cells induces apoptosis and inhibits proliferation. Our results suggest that a consequence of loss of RB1 gene function in retinoblastoma cells is inactivation of TFAP2A and TFAP2B function. We propose that inability to differentiate along the amacrine/horizontal cell lineages may underlie retinoblastoma tumor formation.
Insights
Loss of RB1 gene function in retinoblastoma inactivates TFAP2A and TFAP2B. This may lead to retinoblastoma tumor formation by preventing cell differentiation in the retina.
Area of Science:
- Ophthalmology
- Genetics
- Cell Biology
Background:
- Retinoblastoma is caused by RB1 gene inactivation.
- Chromosome abnormalities, particularly extra copies of 6p, are common in retinoblastoma.
- RB protein interacts with TFAP2 transcription factors.
Purpose of the Study:
- Investigate the role of TFAP2A and TFAP2B in retinoblastoma.
- Determine the relationship between RB1 gene function and TFAP2A/TFAP2B expression.
- Explore the potential of TFAP2A and TFAP2B as therapeutic targets.
Main Methods:
- Analysis of TFAP2A and TFAP2B expression in human retina and retinoblastoma.
- Detection of TFAP2A RNA and protein, and TFAP2B RNA and protein.
- Transfection of retinoblastoma cells with TFAP2A and TFAP2B expression constructs.
Main Results:
- TFAP2A and TFAP2B are expressed in retinal amacrine and horizontal cells.
- Most retinoblastoma cell lines and tumors lack TFAP2A protein and TFAP2B RNA/protein.
- TFAP2A and TFAP2B expression induces apoptosis and inhibits proliferation in retinoblastoma cells.
Conclusions:
- Loss of RB1 gene function in retinoblastoma leads to TFAP2A and TFAP2B inactivation.
- TFAP2A and TFAP2B dysfunction may contribute to retinoblastoma development.
- Inability to differentiate along amacrine/horizontal cell lineages might underlie retinoblastoma formation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Extrinsic Apoptotic Pathway
Apoptosis
Negative Regulator Molecules

